Warren Eric

CIK 00019160481 companyANN ARBOR, MI

SEC Profile

Transactions

Companies

Filings

CIK

0001916048

Recent Transactions

35 trades

Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-04-17$0.98/sh−108→ 370,218 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-03-18$1.49/sh−2,433→ 370,326 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-03-14+213,000→ 372,759 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2025-03-14+191,000→ 191,000 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-02-19$1.87/sh−239→ 159,759 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-01-17$2.26/sh−123→ 159,998 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-12-17$2.43/sh−2,234→ 160,121 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-11-19$2.17/sh−197→ 162,355 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-10-17$2.12/sh−107→ 162,552 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-09-17$1.78/sh−2,608→ 162,659 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-08-19$1.95/sh−211→ 165,267 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-07-17$2.59/sh−108→ 165,478 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-06-18$2.86/sh−2,540→ 165,586 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-05-17$2.48/sh−192→ 168,126 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-03-14+100,000→ 168,318 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2024-03-14+150,000→ 150,000 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-09-20$1.25/sh−742→ 68,318 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-08-18$1.41/sh−243→ 69,060 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-07-19$1.58/sh−106→ 69,303 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-06-21$1.48/sh−603→ 69,409 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-05-17$1.62/sh−219→ 70,012 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-04-19$1.28/sh−115→ 70,231 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-03-17$1.78/sh−526→ 70,346 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-03-14+22,300→ 70,872 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2023-03-14+94,500→ 94,500 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-03-07$5.05/sh−5,090→ 48,572 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-10-18$7.69/sh−107→ 53,662 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-09-19$6.92/sh−255→ 53,769 total
Purchase
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-08-31$7.46/sh+1,000→ 54,024 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-08-17$6.82/sh−199→ 53,024 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-07-19$6.58/sh−431→ 53,223 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-06-17$4.90/sh−256→ 53,654 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2022-06-07+52,000→ 52,000 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-05-17$5.98/sh−196→ 53,910 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-03-14+13,000→ 54,106 total

Companies

Esperion Therapeutics, Inc.
Chief Commercial Officer
$ESPR

Recent Filings

Address

C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150

ANN ARBOR, MI, 48108

View on SEC.gov